Egr-1, PKC Beta, Signalling and Atherosclerosis
Egr-1, PKC Beta, Signalling and Atherosclerosis
批准号:
7162602
负责人:
SHI FANG YAN
金额:
$34.35万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-01-15 至 2009-12-31
关键词:
AccelerationAcuteAddressAffectAgeAnimalsAntigensAortaApolipoprotein EAreaArterial Fatty StreakAtherosclerosisBiochemicalBlood VesselsBreedingCellsCholesterolChronicCollagenComplementComplexDevelopmentDiseaseDominant-Negative MutationEmployee StrikesGene ExpressionGenesGenetic TranscriptionGlucoseGoalsGrowthHumanHypoxiaImmediate-Early GenesImmune responseImmunohistochemistryIn VitroIncubatedInflammatoryIntercellular adhesion molecule 1Interleukin-16LeadLesionLinkLipopolysaccharidesLungMatrix MetalloproteinasesMediatingMediator of activation proteinMononuclearMusNuclear TranslocationPKCbeta1PRKCB1 genePathogenesisPathway interactionsPhagocytesPlant RootsPlasmaPlasminogen Activator Inhibitor 1Polymerase Chain ReactionProcessProductionPropertyProteinsRangeRegulationResearch PersonnelRoleSignal PathwaySignal TransductionSmooth Muscle MyocytesStressStructure of parenchyma of lungTestingTherapeutic InterventionThromboplastinTimeTranscriptTranscriptional ActivationTransgenic MiceTransgenic OrganismsTriglyceridesUp-RegulationVascular Cell Adhesion Molecule-1WeekWild Type MouseZinc Fingersacute stressatherogenesisconceptcytokinein vivoinsightmacrophage scavenger receptorsnoveloxidized low density lipoproteinprogramspromoterresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The immediate early gene, early growth response-1 (egr-1), is linked to maladaptive host response mechanisms m settings of acute cellular perturbation. In addition to acute stress, up regulation of egr-1 may be linked to chronic vascular stress. Transcripts for egr-1 were up regulated in both human and murine atherosclerotic lesions compared to adjacent non-atheromatous plaque, thereby suggesting that the impact of egr-1 in vascular stress might not be limited to the acute setting, rather that egr-1 might impact on chronic vascular perturbation, such as atherosclerosis. Our preliminary studies support this concept, as real time PCR revealed a time-dependent .increase in egr-1 transcripts in aortae of apo E (0) mice versus C57BL/6 controls at ages 6, 8, 10, 14 & 24 weeks. Immunohistochemistry demonstrated that the principal egr-1 expressing cells in atheromata were mononuclear phagocytes (MP) and smooth muscle cells (SMC). Homozygous egr-1 (0) mice in the apolipoprotein E (apo E) (0) background displayed significantly reduced atherosclerosis at the aortic root compared with apo E (0) animals at 14 or 24 weeks of age. In parallel, transcripts for proinflammatory & procoagulant mediators such as JE/MCP- 1, IL-1beta, VCAM-1, ICAM-1, tissue factor (TF) and PAI-1 were significantly diminished in double (0) mice versus mice solely deficient in apo E (0). To test if the PKCbeta axis, a key upstream regulator of egr-1 in acute hypoxia, modulated regulation of egr-1 in chronic vascular stress, we bred homozygous PKCbeta (0) mice into the apo E (0) background. A striking decrease in atherosclerotic lesion area was evident at age 24 weeks in PKCbeta (0)/apo E (0) vs apo E (0) mice. Levels of plasma glucose and cholesterol/triglyceride did not differ between egr- 1 (0)- or PKCbeta (0)/apo E (0) mice versus apo E (0) animals, thus implicating egr-1 and PKCbeta as distinct facets in atherosclerosis. We hypothesize that PKCbeta-dependent up regulation of egr-1 contributes importantly to acceleration of proinflammatory and prothrombotic mechanisms in the vessel wall; processes linked to the pathogenesis of atherosclerosis. We propose to dissect the biochemical and signaling mechanisms by which PKCbeta and egr-1 contribute to lesion development/progression in hypercholesterolemic apo E (0) mice and anticipate that elucidation of the mechanisms by which these factors impact on atherogenesis may highlight new targets for therapeutic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAGE, mitochondria, and tau pathology in AD
-
批准号:10532703
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2019
-
负责人:SHI FANG YAN
-
依托单位:
RAGE, mitochondria, and tau pathology in AD
-
批准号:10320076
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2019
-
负责人:SHI FANG YAN
-
依托单位:
PINK1 signaling and synaptic mitochondria integrity in AD
-
批准号:10091121
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2018
-
负责人:SHI FANG YAN
-
依托单位:
Egr-1, PKC Beta, Signalling and Atherosclerosis
-
批准号:7330488
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2005
-
负责人:SHI FANG YAN
-
依托单位:
Egr-1, PKC Beta, Signalling and Atherosclerosis
-
批准号:7006966
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2005
-
负责人:SHI FANG YAN
-
依托单位:
Egr-1, PKC Beta, Signalling and Atherosclerosis
-
批准号:6867116
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2005
-
负责人:SHI FANG YAN
-
依托单位:
Egr-1, PKC Beta, Signalling and Atherosclerosis
-
批准号:7568212
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2005
-
负责人:SHI FANG YAN
-
依托单位:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
-
批准号:7078584
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2004
-
负责人:SHI FANG YAN
-
依托单位:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
-
批准号:6894666
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:SHI FANG YAN
-
依托单位:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
-
批准号:6822517
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:SHI FANG YAN
-
依托单位:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
-
批准号:7234002
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:SHI FANG YAN
-
依托单位:
Mouse Breeding and Procedure Core
-
批准号:8181500
-
项目类别:
-
资助金额:$31.98万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
AR & AGE-RAGE IN AGING: IMPACT ON ENDOTHELIAL AND VASCULAR STRESS
-
批准号:7796546
-
项目类别:
-
资助金额:$20.9万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
AR & AGE-RAGE IN AGING: IMPACT ON ENDOTHELIAL AND VASCULAR STRESS
-
批准号:8042640
-
项目类别:
-
资助金额:$21.31万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
Mouse Breeding and Procedure Core
-
批准号:8586333
-
项目类别:
-
资助金额:$32.92万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
TRANSGENIC MOUSE AND ANIMAL MANAGEMENT
-
批准号:8378067
-
项目类别:
-
资助金额:$52.42万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
RAGE and the host response to hypoxic stress
-
批准号:8378280
-
项目类别:
-
资助金额:$23.8万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
TRANSGENIC MOUSE AND ANIMAL MANAGEMENT
-
批准号:8235877
-
项目类别:
-
资助金额:$51.93万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
Mouse Breeding and Procedure Core
-
批准号:8976283
-
项目类别:
-
资助金额:$33.54万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
RAGE and the host response to hypoxic stress
-
批准号:8181491
-
项目类别:
-
资助金额:$23.92万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
海外基金